Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
DKK-1 in psoriatic arthritis: Correlation with disease activity and enthesopathy
Marian Aziz Wahba Abdo Wahba; Nagat Mohamed El-Gazzar; Radwa Mahmoud Elsharaby; Samar Abdalhamed Tabra;
Reumatol Clin. 2024;20:14-9
One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry
Clementina López-Medina; Lucía Otero-Varela; Fernando Sánchez-Alonso; Vega Jovaní; Lorena Expósito-Pérez; Sheila Melchor-Díaz; Yanira Pérez-Vera; Paula Pretel-Ruiz; Javier Manero; Antonio Mera-Varela; Lourdes Mateo; Dolores Ruiz-Montesino; José Andrés Lorenzo-Martín; Teresa Pedraz-Penalva; Isabel Castrejón;
Reumatol Clin. 2025;21:
Disease control in patients with psoriatic arthritis in real clinical practice in Spain: MiDAS study
Jordi Gratacós; José L. Pablos; Eugenio de Miguel; Xavier Juanola; Cristina Fernández-Carballido; Rafael Ariza; Pau Terradas-Montana; Carlos Sastré; Cristina Sanabra;
Reumatol Clin. 2023;19:204-10